Materialise stock analysis
Want to see MTLS full AI Analyst Report?
Materialise (MTLS) Stock Price & Analysis
MTLS Stock Chart & Stats
- Day’s Range
- $6.46 - $6.65
- 52-Week Range
- $4.78 - $8.82
- Previous Close
- $6.59
- Volume
- N/A
- Average Volume (3M)
- 220.24K
- Market Cap
- $383.35M
- Enterprise Value
- $403.24M
- Total Cash (Recent Filing)
- $156.13M
- Total Debt (Recent Filing)
- $72.26M
- Price to Earnings (P/E)
- 26.5
- Beta
- 1.39
- Next Earnings
- Feb 18, 2027 (Est.)
- EPS Estimate
- 0.06
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Medical Segment Growth
Medical growth across both devices and software supports a durable healthcare franchise with recurring clinical use cases. New patient-specific workflows, clinical partnerships, and expanded planning tools can deepen adoption and broaden Materialise’s role in regulated medical workflows.
Series Manufacturing And CO-AM Expansion
Strong series-production growth indicates additive manufacturing is moving beyond prototyping into repeat industrial applications. CO-AM platform progress, secure traceability, and aerospace adoption can strengthen customer integration and create more scalable production workflow revenue.
Cash Generation And Balance Sheet
A growing net cash position and stronger free cash flow provide financial flexibility to fund R&D, capacity expansion, and medical innovation without relying heavily on external financing. This resilience supports continued investment while reducing balance-sheet pressure during demand fluctuations.
Bears Say
Software Revenue Decline
Software is strategically important because licenses, subscriptions, and support can provide scalable and recurring revenue. Continued declines, cautious customer spending, and longer sales cycles could delay CO-AM adoption, pressure software profitability, and weaken the mix of higher-quality revenue.
Modest And Pressured Profitability
Materialise is investing for future growth, but elevated R&D and operating costs currently absorb much of the benefit from higher gross profit. With operating margins still modest, sustained spending or slower revenue conversion could keep earnings below the company’s stronger historical levels.
Weak Prototyping And Reported Manufacturing Demand
Soft prototyping demand and reported manufacturing declines show that growth is not broad-based across the portfolio. Although series production is expanding, weaker project activity and portfolio transitions could create uneven utilization, revenue volatility, and pressure on manufacturing profitability.
MTLS FAQ
What was Materialise’s price range in the past 12 months?
What is Materialise’s market cap?
When is Materialise’s upcoming earnings report date?
How were Materialise’s earnings last quarter?
Is Materialise overvalued?
Does Materialise pay dividends?
What is Materialise’s EPS estimate?
How many shares outstanding does Materialise have?
What happened to Materialise’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Materialise?
What is the TipRanks Smart Score and how is it calculated?
Materialise Stock Smart Score
Company Description
Materialise
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
- Sector
- Technology
- Industry
- Software - Application
- CEO
- Brigitte de Vet-Veithen
- Employees
- 2,556
- Website
- www.materialise.com
- Address
- Technologielaan 15, Leuven, VL, 3001, BE
Materialise (MTLS) Earnings & Revenues
MTLS Company Deck
MTLS Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive. Medical revenue grew nearly 10%, core manufacturing series production increased more than 30%, Phits Dynaprint volumes tripled sequentially, cash generation remained strong, and full-year revenue and Adjusted EBIT guidance was reaffirmed. The main challenges were declining software revenue amid cautious customer spending and extended sales cycles, softer prototyping demand, higher R&D and operating expenses, and a relatively low third-quarter Adjusted EBIT margin.
View all MTLS earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 5 | 13 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 1 | 0 | 11 |










